Syneos Health
| Company type | Public (1996-2023) Private (since 2023) |
|---|---|
| Nasdaq: SYNH | |
| Industry | |
| Predecessors | Inventiv Health INC Research |
| Headquarters | , U.S. |
Key people | Costa Panagos (CEO) |
| Services | |
| Revenue | US$5.39 billion (2021) US$5.21 billion (2021) |
| US$266 million (2022) | |
Number of employees | 28,000 (2022) |
| Website | www |
| Footnotes / references | |
Syneos Health (formerly InVentiv Health Incorporated and INC Research) is an American company that provides contract research and commercial services to pharmaceutical and biotechnology companies. Based in Morrisville, North Carolina, the company specializes in helping other companies with late-stage clinical trials, but also provides commercial services to market health treatments.
Syneos Health was formed from the merger of InVentiv Health and INC Research, each formed from the consolidation of several companies in the contract research industry. It was listed on Nasdaq until 2023 when the company was taken private by Elliott Investment Management.